For patients with Acute Lymphoblastic Leukemia (ALL), maintenance therapy is a phase of treatment administered following consolidation therapy. It is specifically designed for patients in the low-risk group and typically involves orally administered medications combined with monthly intravenous chemotherapy. This treatment usually lasts for approximately two years.